Valley National Advisers’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-225
| Closed | -$27K | – | 844 |
|
|
2024
Q4 | $27K | Hold |
225
| – | – | ﹤0.01% | 425 |
|
|
2024
Q3 | $28K | Sell |
225
-126
| -36% | -$15.7K | 0.01% | 413 |
|
|
2024
Q2 | $55K | Buy |
351
+10
| +3% | +$1.57K | 0.01% | 380 |
|
|
2024
Q1 | $44K | Hold |
341
| – | – | 0.01% | 425 |
|
|
2023
Q4 | $32K | Sell |
341
-103
| -23% | -$9.67K | 0.01% | 473 |
|
|
2023
Q3 | $54K | Sell |
444
-44
| -9% | -$5.35K | 0.01% | 376 |
|
|
2023
Q2 | $56K | Buy |
488
+9
| +2% | +$1.03K | 0.01% | 374 |
|
|
2023
Q1 | $61K | Buy |
479
+143
| +43% | +$18.2K | 0.01% | 364 |
|
|
2022
Q4 | $40K | Hold |
336
| – | – | 0.01% | 407 |
|
|
2022
Q3 | $39K | Hold |
336
| – | – | 0.01% | 402 |
|
|
2022
Q2 | $27K | Hold |
336
| – | – | 0.01% | 434 |
|
|
2022
Q1 | $26K | Hold |
336
| – | – | 0.01% | 473 |
|
|
2021
Q4 | $30K | Hold |
336
| – | – | 0.01% | 445 |
|
|
2021
Q3 | $31K | Hold |
336
| – | – | 0.01% | 406 |
|
|
2021
Q2 | $26K | Sell |
336
-1,684
| -83% | -$130K | ﹤0.01% | 444 |
|
|
2021
Q1 | $151K | Buy |
+2,020
| New | +$151K | 0.03% | 236 |
|